ArticleClinical and experimental medicine2023
Feasibility of trimethoprim/sulfamethoxazole desensitization therapy in hematological diseases.
Shuto Negishi et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it